You have 9 free searches left this month | for more free features.

tg-1801

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-Cell Lymphoma Trial in Heidelberg, Melbourne, Nedlands (TG-1801, Ublituximab)

Active, not recruiting
  • B-Cell Lymphoma
  • TG-1801
  • Ublituximab
  • Heidelberg, Victoria, Australia
  • +2 more
Jan 20, 2023